Lupin Debuts CGT-Exclusive Risperidone LAI in U.S. Market
Dateline: November 14, 2025 — Mumbai, India / Baltimore, MarylandLupin has launched its Risperidone Long-Acting Injectable (LAI) in the...
Prescription, Generic, and Over-The-Counter: Drugs & Products.
Milvexian Phase 3 ACS Trial Discontinued After Interim Review
Dateline: November 17, 2025 — Princeton, N.J.In a significant development for anticoagulant therapy, Milvexian (also known as Librexia) —...
Pharma Supply Chains Drive $451B Global Courier Boom
Dublin, November 10, 2025 — A new Research and Markets report forecasts the global B2B Courier, Express, and Parcels...
FDA Clears CAPLYTA® as New Adjunctive Therapy for Depression
Titusville, New Jersey – November 6, 2025 – Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and...
FDA Accepts Achieve Life Sciences’ Cytisinicline NDA for Smoking and Vaping Cessation
Seattle and Vancouver, November 6, 2025 : Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company, announced...
KalVista Pharmaceuticals Highlights EKTERLY®’s Promise for Children and Strong Patient Satisfaction in HAE Treatment
Framingham, Massachusetts & Salisbury, England — November 6, 2025 : KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) presented new data at...
Pasithea Activates UAB Clinical Site for PAS-004 NF1 Trial
MIAMI, November 4, 2025: Pasithea Therapeutics Corp. has announced the activation of a new clinical trial site at the...
Government contract pursuit advances Halberd TBI nasal-spray program
JACKSON CENTER, Pa., November 3, 2025 — Halberd Corporation, in collaboration with Mississippi State University (MSU), announced continued efforts...
Ritedose Expands U.S. Nebulized Drug Portfolio with FDA Approval
COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...
Unicycive Therapeutics to Resubmit OLC NDA After FDA Type A Meeting
Los Altos, California, October 28, 2025 — Unicycive Therapeutics, Inc., a clinical-stage biopharmaceutical company developing treatments for kidney disease,...